Stocks · Health care · Pharmaceutical Preparations

Sarepta Therapeutics, Inc.

SRPT Clue Score48
United States Fiscal year ends December CIK 0000873303 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Stephen Mayo
12 Mar 2026
Director
Sell
7,239
$17.02
$123.21K
Ian Michael Estepan
16 Dec 2025
Chief Operating Officer
Sell
13,187
$22.31
$294.20K
Kathryn Jean Boor
5 Dec 2024
Director
Sell
1,636
$125.55
$205.40K
Ian Michael Estepan
30 Aug 2024
Chief Financial Officer
Sell
5,985
$137.36
$822.10K
Kathryn Jean Boor
11 Mar 2024
Director
Sell
761
$122.93
$93.55K
Stephen Mayo
5 Mar 2024
Director
Sell
3,135
$122.96
$385.48K
Ryan Edward Brown
1 Mar 2024
EVP, General Counsel
Sell
2,000
$125.34
$250.68K
Ian Michael Estepan
1 Mar 2024
Chief Financial Officer
Sell
1,200
$128.30
$153.96K
Bilal Arif
1 Mar 2024
Chief Tech Ops Officer
Sell
457
$129.71
$59.28K
Bilal Arif
1 Mar 2024
Chief Tech Ops Officer
Sell
1,543
$128.58
$198.40K
Stephen Mayo
17 Nov 2022
Director
Sell
858
$109.92
$94.31K
Richard Barry
7 Aug 2020
Director
Sell
3,140
$159.09
$499.54K
Richard Barry
7 Aug 2020
Director
Sell
26,860
$158.43
$4.26M
Richard Barry
15 May 2020
Director
Sell
4,673
$142.05
$663.80K
Richard Barry
15 May 2020
Director
Sell
25,327
$141.12
$3.57M
Richard Barry
27 Jun 2018
Director
Sell
75,000
$130.34
$9.78M
Edward M. MD Kaye
20 Jul 2017
Director
Sell
10,000
$41.00
$410.00K

What was left out

Form 4 filings counted 327
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 63
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 4,825,682
Sales filed before the plan box existed 7
History held since 8 Feb 2007